NEW YORK, April 11, 2016 – By analyzing nearly 500 Mycobacterium tuberculosis genomes and performing functional studies, researchers from the Broad Institute and South Africa's KwaZulu Natal Research Institute for TB and HIV have identified a new mechanism by which the pathogen acquires drug resistance.

NEW YORK, December 21, 2015 – A University of Oxford-led team of researchers has developed a computer program to rapidly detect antibiotic resistance from bacterial genome sequences.

NEW YORK, December 10, 2015 – An international team led by investigators in the UK and Spain has garnered genetic evidence that the tuberculosis-causing pathogen Mycobacterium tuberculosis originated in Africa.

The National Institutes of Health announced that it aims to award $2 million in grant funding in fiscal year 2017 for research around new biomarkers to diagnose active pulmonary tuberculosis (TB) in children, including those infected with HIV.

A retrospective study published online today in Lancet Infectious Diseases suggests mutation patterns found by sequencing many Mycobacterium tuberculosis isolates can provide a framework for predicting drug resistance or susceptibility.

NEW YORK (GenomeWeb News) – Drug firm Sequella today announced the licensing of its B-Smart nucleic acid-based technology to Laboratory Corporation of America Holdings for an undisclosed amount.